Competitors of RPG Life Sciences Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,538 Cr. | 325 | 390/108 | 64.7 | 18.5 | 0.21 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 59.6 Cr. | 80.3 | 92.8/19.6 | 40.8 | 9.58 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 27.2 Cr. | 18.6 | 18.8/7.60 | 160 | 5.00 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 96.6 Cr. | 128 | 155/82.1 | 15.0 | 51.8 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,870 Cr. | 1,126 | 1,335/609 | 31.0 | 190 | 2.00 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 490 Cr. | 21.6 | 29.0/10.2 | 32.7 | 7.24 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.61 Cr. | 15.7 | 28.5/10.8 | 152 | 13.3 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 360 Cr. | 765 | 1,054/650 | 20.7 | 255 | 0.09 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 55.8 Cr. | 18.6 | 27.8/14.6 | 10.1 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 912 Cr. | 310 | 332/144 | 98.2 | 0.40 % | 3.20 % | 5.59 % | 5.00 | |
| Fabino Enterprises Ltd | 5.63 Cr. | 26.8 | 43.8/23.6 | 113 | 19.8 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 21.0 Cr. | 8.44 | 19.4/7.72 | 46.7 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 101 Cr. | 126 | 184/110 | 49.7 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 33.6 Cr. | 1.36 | 3.10/0.95 | 2.26 | 0.00 % | 0.79 % | 0.13 % | 2.00 | |
| Dipna Pharmachem Ltd | 17.9 Cr. | 7.45 | 16.2/7.00 | 16.4 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 16.3 Cr. | 16.2 | 25.8/14.4 | 74.2 | 21.6 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 310 Cr. | 868 | 999/262 | 13.6 | 497 | 0.23 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.5 Cr. | 37.5 | 61.5/30.1 | 33.8 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 23.6 Cr. | 51.7 | 84.4/35.2 | 46.3 | 19.6 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 11.8 Cr. | 4.74 | 26.5/4.43 | 47.4 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 10.5 Cr. | 69.7 | 94.7/31.0 | 9.68 | 85.3 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 8.65 Cr. | 15.8 | 17.4/4.09 | 78.7 | 0.97 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 53.6 Cr. | 71.0 | 160/63.0 | 35.0 | 38.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.00 Cr. | 20.0 | 27.8/14.6 | 16.9 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 114 Cr. | 26.5 | 43.9/22.5 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 19.8 Cr. | 38.9 | 46.0/19.4 | 32.9 | 17.6 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 188 Cr. | 326 | 408/162 | 19.2 | 108 | 1.38 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 21.5 Cr. | 36.5 | 36.5/4.68 | 2.07 | 0.00 % | 13.1 % | 13.8 % | 10.0 | |
| Aurobindo Pharma Ltd | 86,016 Cr. | 1,469 | 1,593/835 | 24.0 | 509 | 0.31 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 155 Cr. | 248 | 307/105 | 19.9 | 67.3 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,018 Cr. | 203 | 265/124 | 17.6 | 58.1 | 1.23 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 64.1 Cr. | 49.1 | 86.1/44.5 | 59.0 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 6,526 Cr. | 1,596 | 1,823/1,004 | 102 | 183 | 0.19 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 5.75 Cr. | 0.87 | 0.94/0.54 | 0.81 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 444 Cr. | 57.9 | 77.7/35.3 | 37.7 | 17.9 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 15.2 Cr. | 26.0 | 29.0/11.9 | 2.92 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 109 Cr. | 65.0 | 71.9/40.2 | 192 | 18.3 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 60,318 Cr. | 28,372 | 30,521/21,907 | 48.7 | 1,741 | 1.45 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,584 Cr. | 616 | 722/371 | 24.8 | 194 | 0.49 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 180 Cr. | 66.6 | 75.8/37.0 | 27.5 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,643 Cr. | 619 | 725/395 | 34.8 | 0.16 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 16,201 Cr. | 1,055 | 1,127/213 | 219 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 806 Cr. | 247 | 291/85.0 | 29.9 | 6.70 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 21.3 | 0.00 % | 51.5 % | 163 % | 2.00 | |
| Venus Remedies Ltd | 462 Cr. | 346 | 430/230 | 16.2 | 365 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,144 Cr. | 732 | 755/399 | 336 | 0.00 % | 0.39 % | 1.17 % | 2.00 | |
| TTK Healthcare Ltd | 2,337 Cr. | 1,661 | 1,923/1,178 | 36.8 | 708 | 0.60 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,15,017 Cr. | 3,397 | 3,591/1,823 | 68.7 | 203 | 0.82 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,473 Cr. | 269 | 304/142 | 49.4 | 41.0 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,920 Cr. | 20.4 | 27.9/7.25 | 71.0 | 3.05 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 31,846 Cr. | 1,250 | 1,289/541 | 132 | 80.6 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,887 Cr. | 133 | 169/60.8 | 12.4 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,53,498 Cr. | 1,890 | 1,960/1,068 | 43.0 | 265 | 0.71 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,477 Cr. | 804 | 830/264 | 195 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,821 Cr. | 333 | 398/112 | 50.0 | 64.0 | 0.12 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 460 Cr. | 1,537 | 1,750/464 | 27.8 | 585 | 0.10 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,404 Cr. | 859 | 960/296 | 205 | 208 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,862 Cr. | 195 | 241/90.7 | 227 | 26.3 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 15,832 Cr. | 6,877 | 7,600/4,449 | 32.2 | 298 | 2.43 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 4,632 Cr. | 2,798 | 2,977/1,290 | 50.2 | 227 | 0.57 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,653 Cr. | 5,207 | 5,643/4,637 | 40.2 | 324 | 0.96 % | 44.9 % | 33.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 134 Cr. | 38.0 | 79.2/35.4 | 20.4 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 26,455 Cr. | 5,788 | 6,453/3,834 | 43.9 | 786 | 0.60 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 295 Cr. | 239 | 325/190 | 20.2 | 69.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,143 Cr. | 352 | 367/112 | 137 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 6,780 Cr. | 1,336 | 1,592/432 | 60.8 | 231 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 19,741 Cr. | 15,441 | 16,525/3,611 | 61.6 | 1,000 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 836 Cr. | 37.5 | 56.5/21.2 | 136 | 47.7 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,883 Cr. | 1,389 | 1,639/724 | 15.2 | 327 | 0.68 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,974 Cr. | 90.8 | 101/31.3 | 42.3 | 16.6 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,366 Cr. | 295 | 329/97.4 | 40.2 | 45.6 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 191 Cr. | 121 | 145/85.2 | 60.3 | 89.9 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 542 Cr. | 152 | 173/97.9 | 589 | 17.9 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 1,00,177 Cr. | 2,195 | 2,312/1,113 | 44.3 | 314 | 0.36 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,334 Cr. | 666 | 814/471 | 13.6 | 296 | 0.27 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 25,909 Cr. | 480 | 518/349 | 108 | 78.1 | 0.17 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 849 Cr. | 818 | 865/320 | 26.4 | 218 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 183 Cr. | 85.0 | 122/60.0 | 55.3 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,446 Cr. | 300 | 370/185 | 24.4 | 102 | 1.00 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 535 Cr. | 333 | 470/248 | 52.6 | 110 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 19,566 Cr. | 1,228 | 1,247/319 | 83.6 | 341 | 0.41 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,597 Cr. | 1,906 | 2,030/1,244 | 50.4 | 188 | 0.64 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,190 Cr. | 449 | 496/270 | 52.3 | 70.9 | 1.11 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 42,005 Cr. | 1,656 | 1,709/933 | 79.2 | 250 | 0.24 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,541 Cr. | 433 | 538/331 | 21.4 | 274 | 1.16 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 3,183 Cr. | 345 | 417/286 | 47.5 | 120 | 0.43 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 50,270 Cr. | 1,781 | 1,831/702 | 278 | 0.14 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 45,271 Cr. | 2,672 | 3,088/1,385 | 58.8 | 105 | 1.20 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,11,989 Cr. | 6,711 | 7,107/5,206 | 20.1 | 1,694 | 0.60 % | 26.5 % | 21.4 % | 5.00 |
| Dishman Carbogen Amcis Ltd | 2,945 Cr. | 188 | 283/133 | 359 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,26,158 Cr. | 1,562 | 1,702/1,132 | 28.4 | 331 | 0.83 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,516 Cr. | 1,910 | 2,159/950 | 30.4 | 276 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 378 Cr. | 144 | 186/72.5 | 25.0 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,347 Cr. | 128 | 150/77.4 | 12.6 | 92.4 | 0.39 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 121 Cr. | 74.1 | 92.0/42.6 | 191 | 11.2 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 41,619 Cr. | 347 | 396/218 | 26.6 | 165 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,920 Cr. | 1,997 | 2,010/892 | 52.7 | 163 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 214 Cr. | 134 | 158/81.2 | 28.4 | 43.4 | 0.89 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 300 | 34.2 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 19,124 Cr. | 7,650 | 8,140/4,050 | 146 | 285 | 0.31 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,273 Cr. | 786 | 863/556 | 53.4 | 99.8 | 0.59 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 249 Cr. | 118 | 145/69.6 | 13.2 | 77.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 72,866 Cr. | 6,094 | 6,440/3,510 | 34.0 | 862 | 0.66 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 23,400 Cr. | 1,190 | 1,304/707 | 37.2 | 245 | 0.92 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 796 Cr. | 1,393 | 1,754/791 | 11.2 | 671 | 0.83 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 41,709 Cr. | 3,339 | 3,486/1,650 | 48.8 | 283 | 1.08 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 5,625 Cr. | 503 | 571/291 | 38.0 | 118 | 1.01 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,637 Cr. | 504 | 635/430 | 35.9 | 128 | 0.20 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 16,153.72 | N/A | 50.12 | N/A | N/A | 16.62 | 15.49 | N/A |
